Xlera8

Jazz Pharmaceuticals Plc vloži patent za CBD pripravek z 90 % CBD in THC – Povezava programa medicinske marihuane

Glede na profil podjetja GlobalData dne Jazz Pharmaceuticals, Cancer treatment biomarkers was a key innovation area identified from patents. Jazz Pharmaceuticalsfebruarja 2024 je bil delež nepovratnih sredstev 47 %. Delež donacij temelji na razmerju med številom podelitev in skupnim številom patentov.

Cbd preparation with at least 90% cbd and thc

Source: United States Patent and Trademark Office (USPTO). Credit: Jazz Pharmaceuticals Plc

A recently granted patent (Publication Number: US11865102B2) discloses a cannabidiol (CBD) preparation with a high concentration of CBD, greater than or equal to 90% (w/w) based on the total amount of cannabinoids in the preparation. The remaining cannabinoids in the preparation include tetrahydrocannabinol (THC), present as a mixture of trans-THC and cis-THC, with a specific ratio ranging from about 0.7:1.0 to about 5.0:1.0. Additionally, the CBD preparation contains not more than 1.5% (w/w) THC, with specific ranges of THC content specified in the claims.

Furthermore, the patent covers the use of this CBD preparation in pharmaceutical compositions for treating epilepsy, specifically targeting conditions such as Dravet syndrome, Lennox Gastaut syndrome, Doose syndrome, or tuberous sclerosis complex (TSC). The method involves administering a therapeutically effective amount of the CBD preparation, with specified dosage ranges from about 5 mg/kg/day to…

Originalna avtorjeva povezava kliknite tukaj, da preberete celotno zgodbo ..

Klepetajte z nami

Zdravo! Kako vam lahko pomagam?